title: Hysteroscopic management of cesarean scar pregnancy after unsuccessful methotrexate treatment.
abstract: Current management of cesarean scar pregnancy is conservative and consists of medical treatment with methotrexate (MTX). We present a report on a woman with this type of pregnancy who had continuous vaginal bleeding and persistent serum levels of beta human chorionic gonadotropin after undergoing curettage and MTX. Eventually, the remaining ectopic gestational tissue was removed by operative hysteroscopy.
authors.affiliation: Department of Obstetrics and Gynecology, Chang Gung University, Tao-Yuan, Taiwan. angel945@adm.cgmh.org.tw
authors.forename: Angel
authors.initials: A
authors.lastname: Chao
authors.forename: Tzu-Hao
authors.initials: TH
authors.lastname: Wang
authors.forename: Chin-Jung
authors.initials: CJ
authors.lastname: Wang
authors.forename: Chyi-Long
authors.initials: CL
authors.lastname: Lee
authors.forename: An-Shine
authors.initials: AS
authors.lastname: Chao
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000627:therapeutic use*; D000328:Adult; D002585:Cesarean Section; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D002921:Cicatrix / Q000150:complications*; D005260:Female; D006801:Humans; D015907:Hysteroscopy; D008727:Methotrexate / Q000627:therapeutic use*; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery*; D017211:Treatment Failure; D016216:Ultrasonography, Prenatal
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D018997:Chorionic Gonadotropin, beta Subunit, Human; D008727:Methotrexate